Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Sleep-disordered breathing including obstructive sleep apnea (OSA) is an extremely common medical disorder associated with important morbidity. The purpose of this study is to understand the clinical features and course of patients with sleep apnea in Korea. Participants who are suspected of sleep apnea due to symptoms such as snoring, witnessed apneas, waking up with a choking sensation, excessive sleepiness, non-restorative sleep, difficulty initiating or maintaining sleep, fatigue or tiredness, and morning headache will be prospectively recruited at the outpatient clinic of Seoul National University Hospital. After polysomnography (PSG) or respiratory polygraphy, patients with sleep apnea including OSA and central sleep apnea (CSA) will be followed regularly. Participants not having sleep apnea (apnea-hypopnea index < 5/hour) will only have a baseline visit. For only participants with the informed consent of donating blood, their blood samples will be collected and stored in the Seoul National University Hospital-Human Biobank (SNUH-HUB).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| obstructive sleep apnea (OSA) | 5 or more predominantly obstructive respiratory events [obstructive and mixed apneas, hypopneas or respiratory effort-related arousals (RERAs)] per hour of sleep during a PSG or per hour of monitoring (respiratory polygraphy) | ||
| central sleep apnea (CSA) | PSG shows all of the following:
| ||
| control | apnea-hypopnea index < 5 per hour of sleep during a PSG or per hour of monitoring (respiratory polygraphy) |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| The number of participants with adherence to positive airway pressure (PAP) therapy | PAP adherence is defined as the use of PAP therapy for ≥4 h/night on ≥70% of nights | Median follow up of 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| The number of deaths | The number of deaths | Median follow up of 15 years |
| The cause of death | The cause of death | Median follow up of 15 years |
| Measure | Description | Time Frame |
|---|---|---|
| Change of FEV1 and FVC in patients with OSA | Change of forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) in patients with OSA | Median follow up of 5 years |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Participants who are suspected of sleep apnea due to symptoms such as snoring, witnessed apneas, waking up with a choking sensation, excessive sleepiness, non-restorative sleep, difficulty initiating or maintaining sleep, fatigue or tiredness, and morning headache will be prospectively recruited at the outpatient clinic of Seoul National University Hospital.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jaeyoung Cho, M.D. | Contact | +82-2-2072-2503 | apricot6@snu.ac.kr |
| Name | Affiliation | Role |
|---|---|---|
| Jaeyoung Cho, M.D. | Seoul National University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul National University Hospital | Recruiting | Seoul | 03080 | South Korea |
Not provided
| ID | Term |
|---|---|
| D012891 | Sleep Apnea Syndromes |
| ID | Term |
|---|---|
| D001049 | Apnea |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D020919 | Sleep Disorders, Intrinsic |
Not provided
Not provided
Not provided
Not provided
Not provided
For only participants with the informed consent of donating blood, their blood samples (serum, plasma, and buffy coat) will be collected and stored in the Seoul National University Hospital-Human Biobank (SNUH-HUB).
| D020920 |
| Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |